| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
CareSource
| Facility | $41,686.94 | $52,480.75 | $63,095.73 | |
Cigna
| Professional | $5.01 | $5.01 | $5.01 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the COVID-19 public health emergency
| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
CareSource
| Facility | $41,686.94 | $52,480.75 | $63,095.73 | |
Cigna
| Professional | $5.01 | $5.01 | $5.01 |